Biomarcadores de las Enfermedades Cardíacas
BIOMARCS
![Foto de Biomarcadores de las Enfermedades Cardíacas](/img/uploaded/e14fc215af57bf9a4f0f552bf7ec9db0.jpg)
![Foto de University of Hull](/img/noimage_org.png)
University of Hull
Kingston upon Hull, Reino UnidoPublications in collaboration with researchers from University of Hull (2)
2022
-
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331